Literature DB >> 25559539

Response letter to the editor.

Siri Atma Greeley.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25559539      PMCID： PMC5399500          DOI： 10.1210/jc.2014-4089

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  4 in total

1.  Phenotypic heterogeneity in monogenic diabetes: the clinical and diagnostic utility of a gene panel-based next-generation sequencing approach.

Authors:  G Alkorta-Aranburu; D Carmody; Y W Cheng; V Nelakuditi; L Ma; Jazzmyne T Dickens; S Das; S A W Greeley; D Del Gaudio
Journal:  Mol Genet Metab       Date:  2014-09-28       Impact factor: 4.797

2.  The cost-effectiveness of personalized genetic medicine: the case of genetic testing in neonatal diabetes.

Authors:  Siri Atma W Greeley; Priya M John; Aaron N Winn; Joseph Ornelas; Rebecca B Lipton; Louis H Philipson; Graeme I Bell; Elbert S Huang
Journal:  Diabetes Care       Date:  2011-01-27       Impact factor: 19.112

3.  Highly sensitive diagnosis of 43 monogenic forms of diabetes or obesity through one-step PCR-based enrichment in combination with next-generation sequencing.

Authors:  Amélie Bonnefond; Julien Philippe; Emmanuelle Durand; Jean Muller; Sadia Saeed; Muhammad Arslan; Rosa Martínez; Franck De Graeve; Véronique Dhennin; Iandry Rabearivelo; Michel Polak; Hélène Cavé; Luis Castaño; Martine Vaxillaire; Jean-Louis Mandel; Olivier Sand; Philippe Froguel
Journal:  Diabetes Care       Date:  2013-09-16       Impact factor: 19.112

4.  Improved genetic testing for monogenic diabetes using targeted next-generation sequencing.

Authors:  S Ellard; H Lango Allen; E De Franco; S E Flanagan; G Hysenaj; K Colclough; J A L Houghton; M Shepherd; A T Hattersley; M N Weedon; R Caswell
Journal:  Diabetologia       Date:  2013-06-15       Impact factor: 10.122
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.